TILS.L Share News (TILS)
TILS Share
TILS Share
TILS Share
TILS Share
TILS
TILS Share
TILS Broker
TILS Directors
TILS Financial
TILS
TILS Short
TILSThu, 18th Jun 2020 18:30
Tiziana Life Sciences PLC - London-based oncology and immunology treatments - Gregor MacRae steps down as director with immediate effect. Says looking for new non-executive director with Nasdaq audit committee experience.
Current stock price: 90.00 pence
Year-to-date change: up more than 100%, 41.00p on January 2
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Tiziana Life Sciences has been granted an exclusive license to develop and commercialise Novimmune SA's CD3 receptor monoclonal antibody foralumab. Foralumab can be utilised for a range of autoimmune and inflammatory diseases, such multiple sclerosis, type-1 diabetes, inflammatory bowel disease, pso
Read more